ArticleACS omega2026
One-Step Synthesis of Cytocompatible Brushite-Mineralized Gellan Gum/Alginate Microgels via a Temperature-Controlled Approach.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Injectable bioactive microgels (MGs) are in high demand in minimally invasive bone regeneration, but their fabrication presents significant challenges. Specifically, creating composite MGs that are structurally stablerequiring high polymer concentrationsand containing a bioactive mineral phase is technologically difficult due to high viscosity, leading to inconsistent particle formation and system clogging. Our objective was to develop a novel temperature-controlled emulsification method to overcome these limitations and to produce and characterize MG from a brushite-mineralized highly concentrated gellan gum/sodium alginate (GG/SA). The setup allowed us to successfully produce uniform spherical MG with a controllable mineral content of up to 30% and a mean diameter below 100 μm. SEM/EDS, FTIR, XRD, and TG analyses confirmed the successful incorporation of a nanocrystalline brushite phase, which provided significant structural stability to MGs.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.